These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32869416)

  • 1. Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole.
    Kobayashi R; Matsushima S; Hori D; Sano H; Suzuki D; Kishimoto K; Nakano T; Yanagi M; Kodama K; Kobayashi K
    Pediatr Int; 2021 May; 63(5):550-555. PubMed ID: 32869416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
    Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
    Sano H; Kobayashi R; Hori D; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
    J Microbiol Immunol Infect; 2018 Apr; 51(2):260-266. PubMed ID: 27329132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
    Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
    Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations.
    Cannon JP; Garey KW; Danziger LH
    Pharmacotherapy; 2001 Sep; 21(9):1107-14. PubMed ID: 11560200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
    Maertens JA; Madero L; Reilly AF; Lehrnbecher T; Groll AH; Jafri HS; Green M; Nania JJ; Bourque MR; Wise BA; Strohmaier KM; Taylor AF; Kartsonis NA; Chow JW; Arndt CA; DePauw BE; Walsh TJ;
    Pediatr Infect Dis J; 2010 May; 29(5):415-20. PubMed ID: 20431381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia.
    Miyao K; Sawa M; Kurata M; Suzuki R; Sakemura R; Sakai T; Kato T; Sahashi S; Tsushita N; Ozawa Y; Tsuzuki M; Kohno A; Adachi T; Watanabe K; Ohbayashi K; Inagaki Y; Atsuta Y; Emi N
    Int J Hematol; 2017 Jan; 105(1):79-86. PubMed ID: 27696283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children.
    Sunakawa K; Tsukimoto I; Tsunematsu Y; Honda M; Iwai N; Maniwa T; Haigo H; Suzuki K; Mori T
    J Infect Chemother; 2012 Aug; 18(4):456-65. PubMed ID: 22286407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.
    Annino L; Chierichini A; Anaclerico B; Finolezzi E; Norata M; Cortese S; Cassetta MI; Fallani S; Novelli A; Girmenia C
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2596-602. PubMed ID: 23529741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
    Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
    CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia.
    Noguchi S; Takahashi N; Ito M; Teshima K; Yamashita T; Michishita Y; Ohyagi H; Shida S; Nagao T; Fujishima M; Ikeda S; Ito I; Fujishima N; Kameoka Y; Saitoh H; Tagawa H; Hirokawa M; Sawada K
    Int J Clin Oncol; 2013 Dec; 18(6):983-7. PubMed ID: 23076821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
    Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
    Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
    Yamashita C; Takesue Y; Matsumoto K; Ikegame K; Enoki Y; Uchino M; Miyazaki T; Izumikawa K; Takada T; Okinaka K; Ueda T; Miyazaki Y; Mayumi T
    J Infect Chemother; 2020 Jun; 26(6):596-603. PubMed ID: 32171659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
    Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
    Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
    Koh H; Hino M; Ohta K; Iino M; Urase F; Yamaguchi M; Yamanouchi J; Usui N; Yoshida M; Tanimoto M; Ohyashiki K; Urabe A; Tamura K; Kanamaru A; Masaoka T
    J Infect Chemother; 2013 Dec; 19(6):1126-34. PubMed ID: 23813092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
    Yeh TC; Hou JY; Huang TH; Lu CH; Sun FJ; Huang HM; Liu HC
    Sci Rep; 2021 Oct; 11(1):21142. PubMed ID: 34707164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.
    Ellis M; Frampton C; Joseph J; Alizadeh H; Kristensen J; Hauggaard A; Shammas F
    J Med Microbiol; 2006 Oct; 55(Pt 10):1357-1365. PubMed ID: 17005784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
    Hitoto H; Pihet M; Weil B; Chabasse D; Bouchara JP; Rachieru-Sourisseau P
    Mycopathologia; 2010 Sep; 170(3):161-4. PubMed ID: 20340045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.